NRXP
NRx Pharmaceuticals, Inc.NASDAQHealthcare$2.20+1.85%ClosedMarket Cap: $38.0M
As of 2026-04-06
Insider Statistics (Q4 2024)
Purchases
1
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$1.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue Feb 17 | Casper Joseph Michael | officer: Chief Operating Officer | Sell | 100,000 | $2.39 | 100,000 |
| Tue Feb 17 | Casper Joseph Michael | officer: Chief Operating Officer | Sell | 100,000 | $2.39 | 0 |
| Wed Sep 10 | Javitt Jonathan C | director, 10 percent owner, officer: Chairman and Chief Scientist | Sell | 125,000 | $1.73 | 125,000 |
| Wed Sep 10 | McBride Dennis | director | Sell | 25,000 | $1.73 | 25,000 |
| Wed Sep 10 | Hurvitz Chaim | director | Sell | 25,000 | $1.73 | 25,000 |
| Wed Sep 10 | Flynn Patrick John | director | Sell | 50,000 | $1.73 | 50,000 |
| Thu Aug 21 | B Group, Inc. | 10 percent owner | Sell | 0 | $0.00 | 3,000,000 |
| Tue Feb 11 | ABRAMS MICHAEL S | officer: Chief Financial Officer | Sell | 50,000 | $2.94 | 50,000 |
| Wed Dec 18 | Javitt Jonathan C | director, 10 percent owner, officer: Chairman and Chief Scientist | Buy | 40,000 | $1.17 | 84,634 |
| Fri Nov 22 | ABRAMS MICHAEL S | Sell | 0 | $0.00 | 0 |